NCT06825572View on ClinicalTrials.gov

MSC-EVs in Acute/ Acute-on-Chronic Liver Failure After Liver Transplantation

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

March 30, 2026

Study Completion Date

September 30, 2026

Conditions
Liver FailureMesenchymal Stem CellExtracellular Vesicles
Interventions
BIOLOGICAL

MSC-EVs

10 E10 MSC-EV particles per 100ml for a single dose. No prior HLA matching between MSC donors and recipients or liver donors

Trial Locations (1)

510630

Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou

All Listed Sponsors
lead

Third Affiliated Hospital, Sun Yat-Sen University

OTHER